Nearly two-thirds of community pharmacies had trouble ordering the popular attention-deficit/hyperactivity disorder drug Adderall at the end of July and beginning of August, at a time when demand is at all-time highs.
The National Community Pharmacists Association surveyed store owners and managers about their experiences purchasing brand and generic Adderall between July 25 and Aug. 5. Of the 358 who responded, 64% said that the medicines were on backorder, the group said.
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.